Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1Myeloid 1

Conditions

Mycoses 3Hematologic Neoplasms 3Leukemia 2Invasive Fungal Infections 2Infections 2Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Follicular 1Lymphoma 1Leukemia, Myeloid, Acute 1Immunologic Deficiency Syndromes 1

Interventions

liposomal amphotericin B 2Voriconazole 2Ribavirin 2Levofloxacin 2Fluconazole 2Ciprofloxacin 2Cefazolin 2telaprevir 1peginterferon alfa-2a 1lime 1human papillomavirus vaccine, L1 type 16, 18 1amphotericin B, deoxycholate drug combination 1Vancomycin 1Valacyclovir 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Therapeutics 1Tazobactam 1Surgical Procedures, Operative 1Sulfamethoxazole 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Palivizumab 1Olive Oil 1Ofloxacin 1Nystatin 1Moxifloxacin 1Itraconazole 1Diet 1Cefepime 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Infections × Voriconazole × Clear all
NCT00075803 2023-01-04

BMT CTN 0101

Medical College of Wisconsin

Phase 3 Completed
600 enrolled 22 charts
LymphoidMyeloidOther hematologic neoplasm

Infections, Leukemia, Lymphoma, Myelodysplastic-Myeloproliferative Diseases

NCT00015665 2008-03-04

Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
40 enrolled
Lymphoid

Immunologic Deficiency Syndromes, Infections, Lymphoma, Follicular, Mycoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡